Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant By Reuters Economy September 17, 2024 (Reuters) -Elon Musk’s brain-chip startup Neuralink said on Tuesday its implant aimed at restoring vision received the U.S. Food and…
Analysts weigh in on FDA’s approval for Amgen’s small cell cancer drug By Investing.com Stocks May 17, 2024 The U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to Amgen’s (NASDAQ:) new drug, tarlatamab, marketed as…